53 related articles for article (PubMed ID: 10964422)
1. Evaluation of in vitro bone resorption: high-performance liquid chromatography measurement of the pyridinolines released in osteoclast cultures.
Lorget F; Mentaverri R; Meddah B; Cayrolle G; Wattel A; Morel A; Schecroun N; Maamer M; de Vernejoul MC; Kamel S; Brazier M
Anal Biochem; 2000 Sep; 284(2):375-81. PubMed ID: 10964422
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay.
Foged NT; Delaissé JM; Hou P; Lou H; Sato T; Winding B; Bonde M
J Bone Miner Res; 1996 Feb; 11(2):226-37. PubMed ID: 8822347
[TBL] [Abstract][Full Text] [Related]
3. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
Kamel S; Brazier M; Neri V; Picard C; Samson L; Desmet G; Sebert JL
J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
[TBL] [Abstract][Full Text] [Related]
4. Reversible inhibition of osteoclastic activity by bone-bound gallium (III).
Blair HC; Teitelbaum SL; Tan HL; Schlesinger PH
J Cell Biochem; 1992 Apr; 48(4):401-10. PubMed ID: 1577877
[TBL] [Abstract][Full Text] [Related]
5. A gamma-glutamyl peptide isolated from onion (Allium cepa L.) by bioassay-guided fractionation inhibits resorption activity of osteoclasts.
Wetli HA; Brenneisen R; Tschudi I; Langos M; Bigler P; Sprang T; Schürch S; Mühlbauer RC
J Agric Food Chem; 2005 May; 53(9):3408-14. PubMed ID: 15853380
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
7. [Effects of L-threonate on bone resorption by osteoclasts in vitro].
He JH; Tong NW; Li HQ; Wu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):225-8. PubMed ID: 15807273
[TBL] [Abstract][Full Text] [Related]
8. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
9. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
10. Variation in the sizes of resorption lacunae made in vitro.
Jones SJ; Boyde A; Ali NN; Maconnachie E
Scan Electron Microsc; 1986; (Pt 4):1571-80. PubMed ID: 3810027
[TBL] [Abstract][Full Text] [Related]
11. Family 2 cystatins inhibit osteoclast-mediated bone resorption in calvarial bone explants.
Brand HS; Lerner UH; Grubb A; Beertsen W; Nieuw Amerongen AV; Everts V
Bone; 2004 Sep; 35(3):689-96. PubMed ID: 15336605
[TBL] [Abstract][Full Text] [Related]
12. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
Shorey S; Heersche JN; Manolson MF
Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
[TBL] [Abstract][Full Text] [Related]
13. Regulation and enzymatic basis of bone resorption by human osteoclasts.
Fuller K; Kirstein B; Chambers TJ
Clin Sci (Lond); 2007 Jun; 112(11):567-75. PubMed ID: 17241109
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators.
Grimandi G; Soueidan A; Anjrini AA; Badran Z; Pilet P; Daculsi G; Faucheux C; Bouler JM; Guicheux J
Microsc Res Tech; 2006 Aug; 69(8):606-12. PubMed ID: 16718652
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.
Mulari MT; Qu Q; Härkönen PL; Väänänen HK
Calcif Tissue Int; 2004 Sep; 75(3):253-61. PubMed ID: 15148559
[TBL] [Abstract][Full Text] [Related]
17. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
19. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
20. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
